Cartilage Inc.
Irvine, CA Cartilage Inc.
- UEI
- C47HFKTMNMA4
- CAGE
- 89M68
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 20 Whistler Ct, Irvine, CA 92617, USA
- Website
- cartilage.tech
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Chondrofluid for arthroscopic knee cartilage repair - project summary minor injuries to articular cartilage can initiate… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $0 | |
| Sbir phase i: development of a biological adhesive for the fixation and integration of cartilage implants | Division of Industrial Innovation | $256,000 | |
| Evaluation of hyaleo pre-clinical safety and efficacy for healing large cartilage defects in the knee | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $252,131 |
About Cartilage Inc.
Cartilage Inc. is a leading biotech company dedicated to developing innovative solutions for cartilage regeneration. Its mission is to revolutionize the treatment of cartilage damage and osteoarthritis by providing effective and long-lasting therapies. Cartilage Inc. is a for-profit organization based in the United States.
Cartilage Inc. has received several federal grant awards to support its work in developing cartilage repair products and technologies. In 2023, the company received a $252,127 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop Chondrofluid, an injectable, biologically active cartilage repair product for arthroscopic treatment of chondral defects in the knee. The key objectives included validating Chondrofluid's use in an in vivo preclinical minipig model to treat partial-thickness and full-thickness cartilage defects. In 2021, Cartilage Inc. was awarded a $256,000 Project Grant from the National Science Foundation Division of Industrial Innovation to develop a biological adhesive for the fixation and integration of cartilage implants. Additionally, in 2020, the company received a $252,131 Project Grant from NIAMS to evaluate the pre-clinical safety and efficacy of Hyaleo, a product for healing large cartilage defects in the knee. These awards demonstrate Cartilage Inc.'s expertise in developing innovative cartilage repair solutions through federal grant programs aimed at fostering biomedical research and engineering innovation.
Quick answers
What is Cartilage Inc.'s UEI?
Cartilage Inc.'s Unique Entity ID (UEI) in SAM.gov is C47HFKTMNMA4.
What is Cartilage Inc.'s CAGE code?
Cartilage Inc.'s CAGE code is 89M68.
What is Cartilage Inc.'s primary NAICS code?
Cartilage Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cartilage Inc. located?
Cartilage Inc.'s physical address in SAM.gov is 20 Whistler Ct, Irvine, CA 92617, USA.
Is Cartilage Inc. registered in SAM.gov?
Yes. Cartilage Inc.'s SAM.gov registration is active through December 22, 2026.
What is Cartilage Inc.'s most recent federal award?
Cartilage Inc.'s most recent federal grant award is Chondrofluid for arthroscopic knee cartilage repair - project summary minor injuries to articular cartilage can initiate… (R41AR081741), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on September 21, 2023.
On GovTribe
See Cartilage Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors